6 / 16
Page 21
allied
academies
Current Trends in Cardiology | Volume: 03
10
th
WORLD HEART CONGRESS
&
6
th
International Congress on
CARDIOLOGY AND CARDIAC SURGERY
December 02-03, Dubai, UAE
Joint event on
Curr Trend Cardiol, Volume: 03
"Life support-based comprehensive treatment regimen” in fulminant myocarditis
treatments
Chen Chen, Dao Wen Wang
Tongji Hospital and Medical College, China
F
ulminant myocarditis is caused majorly by the infection
of various viruses. It arises quickly, progresses rapidly,
and may lead to severe heart failure or circulatory failure
presenting as hypotension and cardiogenic shock in a
short time, and its mortality is up to 50-70%. The most
importantly, there are no treatment options, and no
treatment guidelines or expert consensus statement.
Here, we provide first expert consensus, Chinese Society of
Cardiology Expert Consensus Statement on the Diagnosis
and Treatment of Fulminant Myocarditis, based on the data
of our recent registered clinical trial. In this statement, we
described its clinical features and diagnostic criteria, and
importantly,firsttimewedescribedanewtreatmentregimen,
“life support-based comprehensive treatment regimen”.
This treatment regimen includes serious managements
of nutrients and fluids, sufficient doses of glucocorticoid,
immunoglobulin, antiviral reagents, continuous renal
replacement therapy and life-support treatments including
applications of mechanical respirators and circulatory
support systems, intraaortic balloon pulsation (IABP) and
extracorporeal membrane oxygenation (ECMO) as well as
cardiac pacemaker if it is needed.
Our practice in multiple cardiac centers demonstrates
this treatment can dramatically lower the mortality of the
patients with fulminant myocarditis.
e:
chenchen@tjh.tjmu.edu.cn